Twenty-seven states, including Illinois and Wisconsin, and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent.

Bankrupt DNA testing company 23andMe Holding (OTC:MEHCQ) is set to hold a second auction to sell its assets, including customers’ genetic data, after a group led by its former CEO Anne Wojcicki submitted a $305M bid,

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.

PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court’s approval to buy the struggling firm.

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to auction off personal genetic information without their customers’

Lawmakers want to know what will be done to make sure the data will stay out of the hands of adversaries like China.

The bipartisan lawsuit was filed on Monday in St. Louis alongside a separate objection to the bankruptcy sale and is being led by Republic Missouri Attorney General Andrew Bailey. Weiser, a Democrat, said any information collected by 23andMe is too sensitive to be sold without each person’s expressed and informed consent.

WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of 23andMe’s customers’ genetic data while separately working for a major bidder for the assets,